12:00 AM
 | 
Nov 05, 2012
 |  BC Week In Review  |  Company News  |  Deals

Ensemble Therapeutics, Boehringer Ingelheim deal

Ensemble partnered with Boehringer to use Ensemble's Ensemblin technology to discover macrocyclic drug candidates against undisclosed targets chosen by Boehringer. Ensemble will receive undisclosed...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >